Distinct antibody species: structural differences creating therapeutic opportunities
about
Engineered Autonomous Human Variable DomainsRational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β2 Adrenergic Receptor Ligands.Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis.Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity.Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging.Escherichia coli surface display for the selection of nanobodies.
P2860
Q36140177-4101D8C7-2461-4F70-B214-B0EB56E44EEAQ38816551-1B55322A-F68C-4712-A3F6-2705C1F79001Q39372488-2D0D2589-E310-4BA4-9CF0-DE77CB2B202BQ39437960-C9F6DB7F-1C4B-4B03-A3FB-34BC3698CC9EQ41828763-2A0ECC87-4488-4F3B-A8EA-27466AACB057Q41918644-F6D03DAB-4221-4C8F-9398-8B5E612B2B13Q42770832-2D95F000-DE48-428A-BB46-8CF4758E6311
P2860
Distinct antibody species: structural differences creating therapeutic opportunities
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Distinct antibody species: structural differences creating therapeutic opportunities
@en
type
label
Distinct antibody species: structural differences creating therapeutic opportunities
@en
prefLabel
Distinct antibody species: structural differences creating therapeutic opportunities
@en
P2860
P1476
Distinct antibody species: structural differences creating therapeutic opportunities
@en
P2093
Serge Muyldermans
Vaughn V Smider
P2860
P356
10.1016/J.COI.2016.02.003
P577
2016-02-25T00:00:00Z